A.M. Vitals: Genzyme Points to MS Drug As Sign Sanofi Bid is Too Low

A.M. Vitals: Genzyme Points to MS Drug As Sign Sanofi Bid is Too Low

Laura Landro

Also: Most C-sections performed before labor starts; American companies push into Chinese electronic medical record market; investigators looking at health-care credit cards.

Read more this great post here

No comments yet. Be the first.

Leave a reply

 
Google
Web ekstrapalma.com

RSS Health Care Blog News